| Literature DB >> 21076980 |
Nataša Obermajer1, Sara Sattin, Cinzia Colombo, Michela Bruno, Urban Svajger, Marko Anderluh, Anna Bernardi.
Abstract
In this article, we describe the design, synthesis and activity evaluation of glycomimetic DC-SIGN antagonists, that use a mannose residue to anchor to the protein carbohydrate recognition domain (CRD). The molecules were designed from the structure of the known pseudo-mannobioside antagonist 1, by including additional hydrophobic groups, which were expected to engage lipophilic areas of DC-SIGN CRD. The results demonstrate that the synthesized compounds potently inhibit DC-SIGN-mediated adhesion to mannan coated plates. Additionally, in silico docking studies were performed to rationalize the results and to suggest further optimization.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21076980 PMCID: PMC7089406 DOI: 10.1007/s11030-010-9285-y
Source DB: PubMed Journal: Mol Divers ISSN: 1381-1991 Impact factor: 2.943